PacBio to Participate in the BofA Securities 2022 Healthcare Conference

PacBio will present at the BofA Securities 2022 Healthcare Conference on May 12 at 11:20 a.m. PT.

Rhea-AI Summary

PacBio will present at the BofA Securities 2022 Healthcare Conference on May 12 at 11:20 a.m. PT. The presentation will be available via live webcast on their investors page, with a replay for 30 days post-event. The conference takes place in Las Vegas, Nevada.

PacBio, traded under the symbol PACB, focuses on advanced sequencing technologies to aid scientists in addressing complex genetic issues. Their offerings include HiFi long read and SBB short read sequencing, applicable in various research areas such as oncology and infectious diseases.

Argus Session date unavailable

-4.67% session move Open Argus

Details

News Market Reaction – PACB

The recorded move for PACB in the trading session of this news was -4.67%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.

PacBio’s management is scheduled to present on Thursday, May 12 at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time. The live webcast can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the presentation.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB® short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information please visit www.pacb.com and follow @PacBio.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacb.com

Media:
Lizelda Lopez
pr@pacb.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is PacBio's presentation at the BofA Securities Healthcare Conference?

PacBio will present on May 12, 2022, at 11:20 a.m. Pacific Time.

Where can I watch the PacBio presentation live?

The live webcast can be accessed on PacBio's investors page at investor.pacificbiosciences.com.

What is PacBio focusing on in their technologies?

PacBio is focused on advanced sequencing technologies, including HiFi long read and SBB short read sequencing.

What are the applications of PacBio's sequencing technologies?

PacBio's technologies are used in human germline sequencing, plant and animal sciences, infectious diseases, oncology, and more.

What stock symbol does PacBio trade under?

PacBio trades under the stock symbol PACB.